Home | Articles
Published on:June 2018
Indian Journal of Pharmaceutical Education and Research, 2018; 52(3):532-539
Original Article | doi:10.5530/ijper.52.3.61

Oral Mucositis Severity Assessment by Supplementation of High Dose Ascorbic Acid During Chemo and/or Radiotherapy of Oro-Pharyngeal Cancers – A Pilot Project


Authors and affiliation (s):

Nallan CSK Chaitanya1*, Arvind Muthukrishnan2, Kovur Purushotham Rao3, Danam Reshma Priyanka4, Polepeddi Ujwala4, Hari Abhijeeth4, Ajaykartik Kovur4, Athmakoor Nikhil Kumar5

1Research Scholar, Saveetha Univeristy, Thandalam, Chennai, INDIA.

2Department of Oral Medicine and Radiology, Saveetha Dental College, Saveetha University, Chennai, INDIA.

3Department of pharmacy, HKE’s Society of Pharmacy College, Gulbarga, INDIA.

4Department of Oral Medicine and Radiolog, Panineeya Mahavidyalaya Institute of Dental Sciences and Research Centre, Kamala Nagar Road Number- 5, Chaitanyapuri, Dilsukhnagar, Hyderabad, INDIA.

5Department of Radiation Oncology, MNJ Institute of Oncology and Regional Cancer Center, Redhills, Hyderabad, INDIA.

Abstract:

Introduction: Prevention or control of oral mucositis during cancer therapy can lead to better treatment outcome. The present study was aimed to evaluate the effect of high dose oral ascorbic acid on severity of oral mucositis induced during treatment period. Methods: After informed consent, patients of both the gender with age 18-70 years, were divided into: Group A (n=19) served as controls with no intervention, Group B (n=20) undergoing chemo-radiotherapy and Group C (n=20) receiving conventional radiotherapy. Subjects in group B and group C received varying oral doses of vitamin C (2, 3 and 4 g). The therapy initiated 48 h before the onset of cancer treatment. Intensity of oral mucositis was analysed on day 0, 7, 14, 21, 28 and 35, using WHO grading of oral mucositis by a radiation oncologist. Results: One-Way ANOVA revealed only mild mucositis in experimental group B and C when compared to group A (control) and significant reduction in mucositis in-group B and C with 2 g and 4 g. WHO grade 4 mucositis were less reported in ascorbic acid supplementation groups. Radiotherapy group (Mean SD 3.2+ 1.64) performed better than the chemo-radiotherapy group (Mean SD 3.7 + 1.38). Over all, those receiving 4gm (mean SD 1.3) had shown significantly better scores than those with 2g (mean SD 3.38) and 3 g (mean SD 4.19). Conclusion: The study showed that oral ascorbic acid during radiotherapy and chemo-radiotherapy could alleviate the severity of oral mucositis in patients with cancers.

Key words: Ascorbic acid, Mucositis, Grading of mucositis, Radiotherapy, Chemotherapy.

 

Articles in PDF, ePUB and Full text are attached to this page. In order to download, print or access these formats you must be logged in.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
2 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.




 

User login

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
4 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs